References
- Brelsford M, Beute TC. Preventing and managing the side effects of isotretinoin. Semin Cutan Med Surg. 2008;27:197–206.
- Thielitz A, Krautheim A, Gollnick H. Update in retinoid therapy of acne. Dermatol Ther. 2006;19:272–279.
- Charakida A, Mouser PE, Chu AC. Safety and side effects of the acne drug, oral isotretinoin. Expert Opin Drug Saf. 2004;3:119–129.
- Ertam I, Alper S, Unal I. Is it necessary to have routine blood tests in patients treated with isotretinoin? J Dermatolog Treat. 2006;17:214–216.
- Schweinfurth N, Hohmann S, Deuschle M, Lederbogen F, Schloss P. Valproic acid[c1] and all trans retinoic acid differentially induce megakaryopoiesis and platelet-like particle formation from the megakaryoblastic cell line MEG-01. Platelets. 2010;21:648–657.
- Yu C, Liu Y, Miao Z, Yin M, Lu W, Lv Y, Retinoic acid enhances the generation of hematopoietic progenitors from human embryonic stem cell-derived hemato-vascular precursors. Blood. 2010;116:4786–4794.
- Ganser A, Seipelt G, Verbeek W, Ottmann OG, Maurer A, Kolbe K, Effect of combination therapy with all-trans-retinoic acid and recombinant human granulocyte colony-stimulating factor in patients with myelodysplastic syndromes. Leukemia. 1994;8:369–375.
- Gold EJ, Mertelsmann RH, Itri LM, Gee T, Arlin Z, Kempin S, Phase I clinical trial of 13-cis-retinoic acid in myelodysplastic syndromes. Cancer Treat Rep. 1983;67:981–986.